QIM
IPXL

Quantitative Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Quantitative Investment Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-25,300
Closed -$407K – 938
2017
Q2 		$407K Sell
25,300
-172,600
-87% -$2.55M 0.01% 631
2017
Q1 		$2.5M Buy
197,900
+22,500
+13% +$272K 0.04% 443
2016
Q4 		$2.32M Buy
+175,400
New +$3M 0.06% 451
2015
Q4 		– Sell
-15,200
Closed -$535K – 938
2015
Q3 		$535K Buy
+15,200
New +$685K 0.04% 428

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Quantitative Investment Management's IPXL Position: Q3 2017 in Review

Quantitative Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 25,300 shares — an estimated $407K sold.

Quantitative Investment Management first reported a position in IPXL in Q3 2015 and held it in 4 quarters. The position peaked at $2.5M in Q1 2017. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

  • Quantitative Investment Management reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
  • Quantitative Investment Management sold 25,300 Impax Laboratories, Inc. shares in Q3 2017, an estimated $407K.
  • Quantitative Investment Management first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 4 quarters.
  • Quantitative Investment Management's Impax Laboratories, Inc. position peaked at $2.5M in Q1 2017.
  • 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Quantitative Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.